Phase I Safety and Immunogenicity Trial of Plasmodium vivax CS Derived Long Synthetic Peptides Adjuvanted with Montanide ISA 720 or Montanide ISA 51

We assessed the safety, tolerability, and immunogenicity of a mixture of three synthetic peptides derived from the Plasmodium vivax circumsporozoite protein formulated in Montanide ISA 720 or Montanide ISA 51. Forty healthy malaria-naive volunteers were allocated to five experimental groups (A–E): f...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Herrera, Sócrates, Fernández, Olga Lucía, Vera, Omaira, Cárdenas, William, Ramírez, Oscar, Palacios, Ricardo, Chen-Mok, Mario, Corradin, Giampietro, Arévalo-Herrera, Myriam
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society of Tropical Medicine and Hygiene 2011
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3032485/
https://ncbi.nlm.nih.gov/pubmed/21292873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2011.09-0516
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky